lilly retatrutide trial Eli just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Investigating the “efficacy and safety

doi: 10.1097/MCC.0000000000001294 40

It is the first of these medications to interact with two hormones in the body, which is why researchers believe it manages blood sugar levels better than previous medicines and helps people lose more weight

The ingredients in Activate, particularly the combination of hibiscus and lemon verbena polyphenols, have been shown in clinical studies to modestly increase GLP-1 levels (12-22% above baseline)

It is essentially a paralysis of the bowel

Clinical trials have linked semaglutide, for example, with improvements in chronic kidney disease, blood pressure, certain types of heart failure, and even cognitive decline

[DOI] [PubMed] [Google Scholar] 53.Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes